CONDUCT PROTEIN ANALYSIS SERVICES IN SUPPORT OF CANCER RESEARCH | SAM.gov Opportunity | G2X

CONDUCT PROTEIN ANALYSIS SERVICES IN SUPPORT OF CANCER RESEARCH

Solicitation36C24526Q0565Notice typeCombined Synopsis/SolicitationWashington, DC

Attachments

3 files

Name	Type	Posted	Actions
36C24526Q0565.pdf	PDF	Jun 11, 2026	Download
36C24526Q0565_1.pdf	PDF	Jun 11, 2026	Download
Wage Determination No 2015-4281.pdf	PDF	Jun 11, 2026	Download

Version History

CONDUCT PROTEIN ANALYSIS SERVICES IN SUPPORT OF CANCER RESEARCH

Combined Synopsis36C24526Q0565Jun 11, 2026 · v1

LatestViewing

Opportunity Summary

The Department of Veterans Affairs is seeking protein analysis services to support a longitudinal cancer research study titled AI-Guided Blood Proteomics for Treatment Optimization in Veterans with Metastatic Prostate Cancer. Conducted at the Washington DC VA Medical Center, the study enrolls Veterans with metastatic hormone-sensitive prostate cancer and metastatic castration-resistant prostate cancer. The scope of work involves analyzing serial peripheral blood specimens collected at predefined intervals before, during, and after patient treatment.

This procurement is identified as solicitation number 36C24526Q0565 and is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for Health R&D Services; Health Care Services; Basic Research. No set-aside is designated for this requirement. Performance will take place in Washington, DC, with Veronica B. Dillard serving as the point of contact.

Responses to this combined synopsis/solicitation must be submitted by June 26, 2026. The solicitation includes three attachments: the primary solicitation document, an additional PDF file, and a wage determination. These materials were published and last updated on June 11, 2026.

Generated by Lumen AI

Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.

Opportunity Summary

Opportunity Details

Response deadline: Jun 26, 202614 days remaining
NAICS: 541715 (opens in new tab)
PSC: AN11 (opens in new tab)
Set aside: NONE
Published: Jun 11, 2026
Updated: Jun 11, 2026
Agency: VETERANS AFFAIRS, DEPARTMENT OF (opens in new tab)
Office: VETERANS AFFAIRS, DEPARTMENT OF
Department: —
Source: View on SAM.gov (opens in new tab)

Contact and place of performance

Point of contact: Veronica B. Dillard

Place of performance

Washington, DC 20422

USA

Original Description

AI-Guided Blood Proteomics for Treatment Optimization in Veterans with Metastatic Prostate Cancer.The Washington DC VA Medical Center (DC VAMC) is conducting a longitudinal study enrolling Veterans with metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC). Serial peripheral blood specimens are collected at predefined timepoints before, during, and after treatment.